Prestige Consumer Healthcare
PBH
#4631
Rank
S$3.14 B
Marketcap
S$66.28
Share price
1.36%
Change (1 day)
-22.33%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): S$5.05

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is S$5.01. In 2025 the company made an earnings per share (EPS) of S$4.84 a decrease over its 2024 EPS that were of S$5.47.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$5.054.32%
2025S$4.84-11.4%
2024S$5.47-367.08%
2023S-$2.05-138.33%
2022S$5.3411.7%
2021S$4.7813.6%
2020S$4.21-651.67%
2019S-$0.76-148.78%
2018S$1.56-83.29%
2017S$9.35437.23%
2016S$1.74-34.13%
2015S$2.6452.94%
2014S$1.73-8.11%
2013S$1.88
2011S$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.10 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
S$8.88 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.92 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.66-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.59-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
S$7.85 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
S$2.94-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.94-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
S-$37.65-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
S$1.55-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel